These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3493611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The IgG subclass distribution of thyroid autoantibodies.
    Weetman AP, Cohen S.
    Immunol Lett; 1986 Nov 03; 13(6):335-41. PubMed ID: 3781568
    [Abstract] [Full Text] [Related]

  • 5. IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease.
    Weetman AP, Byfield PG, Black C, Reimer CB.
    Eur J Clin Invest; 1990 Aug 03; 20(4):406-10. PubMed ID: 1977589
    [Abstract] [Full Text] [Related]

  • 6. Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies.
    Latrofa F, Ricci D, Montanelli L, Piaggi P, Mazzi B, Bianchi F, Brozzi F, Santini P, Fiore E, Marinò M, Tonacchera M, Vitti P.
    Clin Exp Immunol; 2014 Dec 03; 178(3):438-46. PubMed ID: 25134846
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin G subclasses of anti-thyroid peroxidase autoantibodies in human autoimmune thyroid diseases.
    Kotani T, Kato E, Hirai K, Kuma K, Ohtaki S.
    Endocrinol Jpn; 1986 Aug 03; 33(4):505-10. PubMed ID: 3792276
    [Abstract] [Full Text] [Related]

  • 8. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B, Lu G, Li M, Cai X, Peng D, Wang Y, Li T, Huang Y, Gao Y, Guo X, Shi B.
    Zhonghua Yi Xue Za Zhi; 2014 Jan 14; 94(2):110-4. PubMed ID: 24721350
    [Abstract] [Full Text] [Related]

  • 9. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease.
    Wilson R, McKillop JH, Henderson N, Pearson DW, Thomson JA.
    Clin Endocrinol (Oxf); 1986 Aug 14; 25(2):151-6. PubMed ID: 3491692
    [Abstract] [Full Text] [Related]

  • 10. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E, Szegedi G, Suranyi P, Juhasz F, Stenszky V, Balazs C, Farid NR.
    Immunol Lett; 1987 May 14; 15(1):77-81. PubMed ID: 3111991
    [Abstract] [Full Text] [Related]

  • 11. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P.
    Q J Med; 1988 Feb 14; 66(250):175-89. PubMed ID: 2902655
    [Abstract] [Full Text] [Related]

  • 12. Do HLA-DR-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid drug treatment?
    Schleusener H, Schwander J, Holl G, Badenhoop K, Hensen J, Finke R, Schernthaner G, Mayr WR, Kotulla P.
    Acta Endocrinol Suppl (Copenh); 1987 Feb 14; 281():318-24. PubMed ID: 2441554
    [Abstract] [Full Text] [Related]

  • 13. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.
    Madec AM, Allannic H, Genetet N, Gueguen M, Genetet G, Fauchet R, Stefanutti A, Orgiazzi J.
    J Clin Endocrinol Metab; 1986 Jan 14; 62(1):117-21. PubMed ID: 3484386
    [Abstract] [Full Text] [Related]

  • 14. Insulin autoantibodies in Graves' disease--before and after carbimazole therapy.
    Armitage M, Franklyn J, Scott-Morgan L, Parr J, Borsey DQ, Sheppard M, Wilkin TJ.
    Diabetes Res Clin Pract; 1990 Mar 14; 8(3):169-76. PubMed ID: 2340791
    [Abstract] [Full Text] [Related]

  • 15. Affinity purification of IgG subclasses and the distribution of thyroid auto-antibody reactivity in Hashimoto's thyroiditis.
    Weetman AP, Black CM, Cohen SB, Tomlinson R, Banga JP, Reimer CB.
    Scand J Immunol; 1989 Jul 14; 30(1):73-82. PubMed ID: 2756340
    [Abstract] [Full Text] [Related]

  • 16. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting.
    Bernard NF, Ertug F, Teboul N, Zhang ZG, Salvi M, Wall JR.
    Autoimmunity; 1991 Jul 14; 10(1):57-63. PubMed ID: 1742423
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H, Fauchet R, Lorcy Y, Gueguen M, Le Guerrier AM, Genetet B.
    J Clin Endocrinol Metab; 1983 Oct 14; 57(4):719-22. PubMed ID: 6688428
    [Abstract] [Full Text] [Related]

  • 18. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease.
    Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR.
    Acta Endocrinol (Copenh); 1989 Jun 14; 120(6):689-701. PubMed ID: 2567102
    [Abstract] [Full Text] [Related]

  • 19. A primary standard for the ELISA of thyroglobulin and microsomal autoantibody IgG subclass associated activity.
    Parkes AB, Howells RD, Mower J, Hall R.
    J Clin Lab Immunol; 1989 Nov 14; 30(3):141-5. PubMed ID: 2642171
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
    Weetman AP, Pickerill AP, Watson P, Chatterjee VK, Edwards OM.
    Q J Med; 1994 Jun 14; 87(6):337-41. PubMed ID: 7913766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.